ArticleFrontiers in pharmacology2022

Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology.

Bingyu Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.